Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice.
about
lncRNA/MicroRNA interactions in the vasculatureEndothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosisTargeting interleukin-1 in heart diseaseNeutrophil elastase promotes interleukin-1β secretion from human coronary endothelium.Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1alphaContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.Innate immunity has a dual effect on vascular healing: suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge.Lack of interleukin-1 signaling results in perturbed early vein graft wall adaptations.Moderate hypoxia potentiates interleukin-1β production in activated human macrophages.The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart StudyReducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation.P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cellsColchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary SyndromeInhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.NADPH oxidase 4 is required for interleukin-1β-mediated activation of protein kinase Cδ and downstream activation of c-jun N-terminal kinase signaling in smooth muscle.A Novel Protective Function of 5-Methoxytryptophan in Vascular InjuryClosing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes.Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feedingSterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility.Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease.A novel mouse model of in situ stenting.Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events.Most important chronic complications of arteriovenous fistulas for hemodialysis.High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration.Estimation of Interleukin-1β Promoter (-31 C/T and -511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients.Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin.IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus.Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms.Reducing Vascular Calcification by Anti-IL-1β Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia.The IL-1RI Co-Receptor TILRR (FREM1 Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease.Detrimental effects of mechanical stretch on smooth muscle function in saphenous veins.Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E-/- model of PAH and atherosclerosis.HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome.
P2860
Q26766577-ED2292F0-166F-49DB-8920-A74720B23501Q26852572-F0F1C5E0-1824-43FF-8FB0-117A1EC502EAQ27009347-80403A7B-246A-4DA7-9A46-6AF2F022D500Q27312465-8DBEA45E-FC38-4E88-AE27-F614865F91DFQ28583222-D1DA0D7C-A1B5-4630-8819-F70034DF2D60Q30318502-9B8DC596-D049-4FC6-B72C-7CCC53049A32Q30319434-A6C917E0-4CDC-4464-AE1C-05FE0746215AQ33685670-684511D6-92EB-4BF7-ABEE-0C37D04E8937Q33730487-79CC85DF-5DF6-412D-A6FF-64D2B7B6A456Q34361972-5B9FE559-6459-473C-AF21-EA66A0437BE3Q34403101-4E9E627C-B519-40AA-8F46-0627636A626DQ35059517-6B7C36D8-6E54-48B6-BDE8-3F51F1270D35Q35649420-B0D325E3-FF81-4E20-B433-C42BA7186923Q36050702-B45F4D09-DC20-4448-86B2-85FF26CF14D8Q36141649-157B6E19-C7FF-4CDC-95A7-C3A8BFCAB0C0Q36340848-A7AE183A-4CA5-42E6-9C42-9D4F047F2514Q36344968-3524E386-5E6E-48F2-9D32-5EC4713565D9Q36501270-9974FDCA-3B6D-467D-8501-5EF999573183Q36871106-E2997883-FA94-43D2-B7C1-CF478F0A49EFQ37026106-2C990EA7-8A01-4F67-865B-6F368E99F5FDQ37064752-735A4CBA-C057-45DA-A2B8-404E28CEA942Q37141472-01F805EA-659E-4E18-9DB5-436A731CAE6AQ37233061-496425E2-31F2-40EA-ADFA-68EF2A35DBD3Q37421811-5EDDA001-5BD2-46C1-95DA-150D08EC18E9Q37467840-237971B4-FAA0-4055-AB25-69010716986AQ38008700-5424AC44-C14C-4D61-8BE0-8AF89C64510AQ38057947-805E2D8B-ADAA-4BCB-8DCD-44507B4E48AFQ38605295-E798DBF1-2D8B-4945-A2E8-DCED1C8F4579Q38752078-4D7C64D8-A98E-4E1F-B72A-357F943960E5Q39102963-35EA28BE-6B59-4BD1-B379-62FCABEB3B8DQ39403443-115E3414-C2B1-4453-B1DB-5DE309D749E8Q39701214-76862368-5779-46C8-959B-EA125D07AC43Q41025441-59B261BF-6E38-4C82-89B4-307F0BBD3686Q41599612-603F259F-12DB-484E-9E21-DB2DB4CA01B6Q42247876-B4DBD38A-D37F-4B99-BB49-E88E3591FD07Q45002999-AA746B4C-BC18-497F-A1F0-FBF396650466Q47871866-B651D298-5875-47B2-AF49-26CB615C8DA0Q48088302-3977115A-680F-4766-8FDC-53BFFF3F662AQ55322256-05FA8710-98D6-4EC6-A869-9EB739446BF3
P2860
Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interleukin-1beta and signalin ...... f neointima formation in mice.
@ast
Interleukin-1beta and signalin ...... f neointima formation in mice.
@en
type
label
Interleukin-1beta and signalin ...... f neointima formation in mice.
@ast
Interleukin-1beta and signalin ...... f neointima formation in mice.
@en
prefLabel
Interleukin-1beta and signalin ...... f neointima formation in mice.
@ast
Interleukin-1beta and signalin ...... f neointima formation in mice.
@en
P2093
P2860
P1476
Interleukin-1beta and signalin ...... of neointima formation in mice
@en
P2093
Andrea King
David Crossman
David Evans
Janet Chamberlain
Rachael Dewberry
Steven Dower
P2860
P304
P356
10.2353/AJPATH.2006.051054
P407
P577
2006-04-01T00:00:00Z